GSK, Theravance Lung Drug Relvar Wins European Green Light

The European Medicines Agency has given the GSK/Theravance collaboration relvar — an inhaled lung drug — approval for sale in Europe. The drug acts to both reduce inflammation in the lungs and open airways.
Reuters